Rehabilitation After Coronary Bypass Grafting. Comparison of Different Types of Rehabilitation Programs
This study has been completed.
Sponsor:
Norwegian University of Science and Technology
Collaborator:
Stiftelsen Helse og Rehabilitering
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00363922
First received: August 10, 2006
Last updated: July 23, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare different types of rehabilitation after coronary bypass surgery. The investigators wish to compare rehabilitation in an institution for four weeks with a home based rehabilitation. They also wish to compare rehabilitation in an institution for four weeks with a rehabilitation program were the patients live at home but visit the hospital twice a week for twelve week. The investigators will measure the patients' physical capacity by measuring their maximal oxygen consumption. The investigators will also analyze their blood and their endothelian function (how well their arteries dilate).
| Condition | Intervention | Phase |
|---|---|---|
|
Coronary Artery Disease |
Behavioral: Rehabilitation in institution Behavioral: Rehabilitation at home Behavioral: Out-patient rehabilitation at the hospital |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Rehabilitation After Coronary Bypass Grafting: Home Based Rehabilitation Versus Rehabilitation in Institution and Rehabilitation in Institution Versus Out-patient Rehabilitation at the Hospital |
Resource links provided by NLM:
MedlinePlus related topics:
Coronary Artery Bypass Surgery
Coronary Artery Disease
Oxygen Therapy
Rehabilitation
U.S. FDA Resources
Further study details as provided by Norwegian University of Science and Technology:
Primary Outcome Measures:
- Maximal oxygen consumption [ Time Frame: At baseline and after 6 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Blood analyses (different markers for cardiovascular risk and endothelian function) [ Time Frame: At baseline and after 6 months ] [ Designated as safety issue: No ]
- Endothelian function (flow mediated dilatation) [ Time Frame: At baseline and after 6 months ] [ Designated as safety issue: No ]
- Quality of life (SF36 and MacNew) [ Time Frame: At baseline and after 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 30 |
| Study Start Date: | September 2006 |
| Study Completion Date: | June 2008 |
| Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Rehabilitation in institution
|
Behavioral: Rehabilitation in institution
Rehabilitation in institution for four weeks. Subjects follow standard rehabilitation in the center.
|
|
Active Comparator: 2
Rehabilitation at home
|
Behavioral: Rehabilitation at home
Subjects get a written prescription of exercise training, diet, etc. to follow at home.
Behavioral: Out-patient rehabilitation at the hospital
This intervention was removed. We never got time to randomize subjects into this category. We had planned to randomize patients from one hospital to either Rehabilitation in institution (rehab center) or rehabilitation at the hospital (out patient). And also patients from another hospital to either rehabilitation in institution (rehab centre) or rehabilitation at home. We have only managed to start the study in this second hospital so far (due to maternity leave and limited time to finish a PhD)
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Coronary artery bypass
Exclusion Criteria:
- Significant lung disease
- Drug abuse
- Pregnancy
- Major physical impairment
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00363922
Locations
| Norway | |
| Norwegian University of Science and Technology | |
| Trondheim, Norway, 7489 | |
Sponsors and Collaborators
Norwegian University of Science and Technology
Stiftelsen Helse og Rehabilitering
Investigators
| Principal Investigator: | Trine T. Moholdt, cand.polit | NTNU |
More Information
Publications:
| Responsible Party: | Norwegian University of Science and Technology |
| ClinicalTrials.gov Identifier: | NCT00363922 History of Changes |
| Other Study ID Numbers: | 4.2006.2070 |
| Study First Received: | August 10, 2006 |
| Last Updated: | July 23, 2012 |
| Health Authority: | Norway:National Committee for Medical and Health Research Ethics |
Keywords provided by Norwegian University of Science and Technology:
|
Coronary Artery Bypass [E04.100.376.719.332] |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on May 21, 2013